Difference between revisions of "Part:BBa K4165088"
HossamHatem (Talk | contribs) |
|||
Line 36: | Line 36: | ||
X-ray | X-ray | ||
https://www.rcsb.org/structure/1FLE | https://www.rcsb.org/structure/1FLE | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/model3.jpg" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | Figure 1.: A graphical illustration showing the domains of TRIM21 (X-Ray diffraction). | ||
Line 50: | Line 47: | ||
NMR: | NMR: | ||
https://www.rcsb.org/structure/2REL | https://www.rcsb.org/structure/2REL | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/model4.jpg" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | Figure 2.: A graphical illustration showing the domains of TRIM21 (NMR). | ||
AlphaFold | AlphaFold | ||
https://alphafold.ebi.ac.uk/entry/P19957 | https://alphafold.ebi.ac.uk/entry/P19957 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Line 76: | Line 62: | ||
</html> | </html> | ||
− | Figure | + | Figure 3.: A graphical illustration showing the domains of TRIM21 (AlphaFold). |
===References=== | ===References=== |
Revision as of 00:18, 12 October 2022
WAP-four disulfide core domain 14 serine protease inhibitor.
This basic part encodes Human serine protease inhibitor WAP-four disulfide core domain 14 which is able to inhibit HtrA1 (BBa_K4165004).
Usage and Biology
This type of family encodes for a type of inhibitor that contains a motif which consists of 8 cysteine residues capable of forming four disulfide bonds at the core of the protease, thus inhibiting its action. The main function of this inhibitor is to prevent elastase-mediated tissue proteolysis. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[1-3].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 132
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 189
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
GC Content% 67.5%
Isoelectric point (PI) 8.641
Charge at pH 7 6.373
Molecular Weight (Protein) 12.27 kDa
PDB structure
X-ray, NMR, and the predicted structures (AlphaFold2) are all present.
X-ray https://www.rcsb.org/structure/1FLE
Figure 1.: A graphical illustration showing the domains of TRIM21 (X-Ray diffraction).
NMR: https://www.rcsb.org/structure/2REL
Figure 2.: A graphical illustration showing the domains of TRIM21 (NMR).
AlphaFold https://alphafold.ebi.ac.uk/entry/P19957
Figure 3.: A graphical illustration showing the domains of TRIM21 (AlphaFold).
References
1. Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389.
2. Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.
3. Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.